Global Oncology Brand & Launch Director

Ipsen; Cambridge (MA); Sur place; USD 191 000 - 270 000; Plein temps

Avantages offerts par ce poste

401(k) with company contributions

Medical, dental, vision insurance

Paid time off

Résumé du poste

Ipsen Biopharmaceuticals Inc. is seeking a Global Marketing Director for Navtemadlin to lead the development and execution of the global commercial and brand strategy.

You will work with Medical Affairs, Strategic Insights, HEOR, Market Access and Pricing to translate asset strategy into an integrated launch plan and lifecycle roadmap. You will build strong affiliate partnerships, align local perspectives with global strategy, and focus on the US market to drive launch readiness and a successful

Qualifications

• Minimum of 10 years in pharmaceutical/biopharmaceutical marketing.
• Significant oncology experience and/or launch experience.

Responsabilités

• Develop and execute global brand strategy for Navtemadlin and drive multi-channel campaigns.
• Lead cross-functional collaboration across Medical Affairs, Strategic Insights, HEOR, Market Access, Pricing and Communications.
• Partner with affiliates to align local market plans with global strategy and enable launch readiness.
• Monitor KPIs and ensure budgetary discipline and timely delivery of campaigns.

Connaissances

Strategic marketing

Global launch experience

Cross-functional leadership

Analytics

Segmentation

Lifecycle management

Budgeting

Communication

Project management

US market experience

Formation

BA/BS in business or related field

MBA or equivalent (preferred)

Description du poste

Ipsen Biopharmaceuticals Inc. is seeking a Global Marketing Director for Navtemadlin to lead the development and execution of the global commercial and brand strategy.

You will work with Medical Affairs, Strategic Insights, HEOR, Market Access and Pricing to translate asset strategy into an integrated launch plan and lifecycle roadmap. You will build strong affiliate partnerships, align local perspectives with global strategy, and focus on the US market to drive launch readiness and a successful